| Programm Freitag, 04.06.2010 Zur Tagesübersicht | ||
08:30-10:00 San Francisco - Plenum | Main session - Part I Diagnosis and treatment of epilepsy Chair: C. W. Hess, Bern, P. Fuhr, Basel | |
| 08:30-09:15 | Update on advanced neurophysiology Ch. Michel, Genève | |
| 09:15-10:00 | Paroxysmal movement disorders - an update K. Bhatia, London; UK | |
| 10:00-10:30 | Kaffeepause in der Industrieausstellung
| |
10:30-12:00 San Francisco - Plenum | Main session - Part II Diagnosis and treatment of epilepsy Chair: M. Seeck, Genève, St. Rüegg, Basel | |
| 10:30-11:15 | Autoimmune channelopathies: the growing spectrum of immunotherapy-responsive neuropsychiatric disorders A. Vincent, Oxford; UK | |
| 11:15-12:00 | On the recognition and survival of images: Single neuron recordings in the human temporal lobe I. Fried, Los Angeles, CA; USA | |
| 12:00-13:30 | Lunch in der Industrieausstellung | |
| 12:15-13:15 Raum Montreal | Industrieforum - organisiert durch UCB Pharma AG Pharmacological management of epilepsy: issues and hope Chairman: A. Rossetti, Lausanne | |
| 12:15-12:20 | Welcome & Introduction A. Rossetti, Lausanne | |
| 12:20-12:45 | AED in monotherapy: Hope for the best, but be prepared for the worst M. Carreño, Barcelona | |
| 12:45-13:10 | Add-on-treatment of refractory epilepsy: Nihilism can be challenged with success S. Shorvon, London | |
| 13:10-13:15 | Closing Remarks A. Rossetti, Lausanne | |
13:30-14:45 | Posterviewing | |
| 14:45-15:00 | Kaffeepause in der Industrieausstellung | |
| 14:30-16:30 Raum Singapore | Afternoon session G: Epilepsy - from Genetics to Therapy and withdrawal of AEDs Organisation: Schweizerische Liga gegen Epilepsie SLgE und Schweizerische Gesellschaft für Neuropädiatrie SGNP Chair: G. Krämer, Zürich, T. Schmitt-Mechelke, Luzern | |
| 14:30-15:10 | Genetics and pathophysiology of idiopathic epilepsies and related disorders H. Lerche, Ulm; Germany | |
| 15:10-15:35 | Therapiedauer bei idiopathischen kindlichen Epilepsien B. Schmitt, Zürich | |
| 15:35-16:00 | Therapiedauer nach akuten symptomatischen Anfällen St. Rüegg, Basel | |
| 16:00-16:30 | Consequences of withdrawal of antiepileptic drugs in adults on seizure-relapse, cognition, quality of life, heart, sex hormones and behavioral aspects M. I. Lossius, Oslo; Norway | |
| 15:00-16:30 Raum Osaka/ Samarkand | Afternoon session H: Higher visual functions: insights from patients with brain damage Organisation: Schweizerische Vereinigung der NeuropsychologInnen SVNP Chair: R. Ptak, Genève | |
| 15:00-15:30 | Simultanagnosia Th. Nyffeler, Bern | |
| 15:30-16:00 | Visual processing of biologically-relevant stimuli: lesion and electrophysio-logical studies A. Pegna, Genève | |
| 16:00-16:30 | Visual object agnosia: when a ball is an orange and vice versa R. Ptak, Genève | |
15:00-16:30 Raum Montreal | SFCNS Stroke campaign 2010 - Part IV Roundtable discussion: Stroke 2010 diagnosis and treatment Moderation: Nicole Westenfelder Moderatorin und Redaktorin der Sendung “Puls“ beim Schweizer Fernseher Teilnehmer | Participants :
| |
16:30-17:00 Raum Montreal |
| |
| ab 17:00 Foyer - 2. OG | Apéro | |
| 17:15-18:15 Raum Montreal | Industrieforum - organisiert durch Novartis Pharma Schweiz AG Symposium: Opening a new path in MS treatment Chair: Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| 17:15-17:20 | Introduction Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| 17:20-17:35 | Challenges in MS therapy PD Dr. med. Myriam Schluep, University Hospital Lausanne | |
| 17:35-17:50 | New treatment approach in MS: an oral S1P receptor modulator PD Dr. med. Michael Linnebank, University Hospital Zurich | |
| 17:50-18:10 | Efficacy and safety of an oral S1P receptor modulator Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| 18:10-18:15 | Questions & Answers All Speakers Closing Remarks Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| zurück | ||
 | ||